Percutaneous transluminal angioplasty: the treatment of choice for renovascular hypertension due to fibromuscular dysplasia.
- 1 June 1982
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 143 (3), 631-637
- https://doi.org/10.1148/radiology.143.3.6210930
Abstract
Renal artery strnoses (23) in 21 hypertensive patients, caused by fibromuscular dysplasia, were treated with percutaneous transluminal angioplasty (PTA). Follow-up over a period of 1-30 mo., including angiography, renal vein renin assay and radionuclide flow studies, was performed in 8 patients, each with 1 stenosis. Dilatation was initially successful in all cases and was successfully repeated in 1 case. The mean systolic pressure decreased by 61.81 mm Hg and the mean diastolic pressure by 36.28 mm Hg in response to treatment. Thirteen patients were cured, 8 were felt to have better control of blood pressure on medication and there were no failures. PTA is a clinically effective method of treating renovascular hypertension due to fibromuscular dysplasia.This publication has 6 references indexed in Scilit:
- Progression of renal artery fibromuscular dysplasia in 42 patients as seen on angiography.Radiology, 1981
- Percutaneous transluminal dilatation of the renal arteries: techniques and results.Radiology, 1980
- Surgical Treatment of Fibromuscular Disease of the Carotid ArteriesArchives of Surgery, 1968
- A pathologic-arteriographic correlation of renal arterial diseaseAmerican Heart Journal, 1966
- Transluminal Treatment of Arteriosclerotic ObstructionCirculation, 1964
- Plasmatic diatrizoate-I131 disappearance and glomerular filtration in the dogAmerican Journal of Physiology-Legacy Content, 1963